Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novo Nordisk A/S (NYSE:NVO)

34.97
Delayed Data
As of 4:02pm ET
 -0.23 / -0.65%
Today’s Change
30.89
Today|||52-Week Range
59.00
-39.79%
Year-to-Date
Should Biotech Investors Worry About Donald Trump?
8:54am / Zacks.com - Paid Partner Content
Better Buy: MannKind Corp. vs. Novo Nordisk
Dec 06 / MotleyFool.com - Paid Partner Content
Stop Listening to 'The Market'
8:11am / TheStreet.com - Paid Partner Content
Novo Nordisk's Tresiba Shows Safe Cardiovascular Profile
Nov 30 / Zacks.com - Paid Partner Content
Trump Warns Investors "I'm Going To Bring Down Drug Prices"
Dec 07 / MotleyFool.com - Paid Partner Content
3 High-Yield Dividend Stocks to Buy in December
Nov 30 / MotleyFool.com - Paid Partner Content
Lilly: Jardiance Label to Add Cardiovascular Indication
Dec 06 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for November 28th
Nov 28 / Zacks.com - Paid Partner Content
Novo Nordisk Files Regulatory Application for Semaglutide
Dec 06 / Zacks.com - Paid Partner Content